Gene Set Enrichment Analysis (GSEA) showed that processes involved in neuroblastoma response to rigosertib included the TP53 pathway, G2M checkpoint, mitotic spindle, and TNF-α signaling via NF-κB (Fig. 3C). This evidence concerns the gene NFKB1 and neuroblastoma.